Albumin-amyloid peptide conjugates and uses thereof

Details for Australian Patent Application No. 2010251961 (hide)

Owner Araclon Biotech S.L.

Inventors Sarasa Barrio, J. Manuel

Agent Fisher Adams Kelly

Pub. Number AU-A-2010251961

PCT Pub. Number WO2010/136487

Priority 09382078.5 26.05.09 EP

Filing date 26 May 2010

Wipo publication date 2 December 2010

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 December 2011 PCT application entered the National Phase

  PCT publication WO2010/136487 Priority application(s): WO2010/136487

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010251966-Combination of a TNF-alpha antagonist and a VEGF antagonist for use in the treatment or prevention of diseases of the eye.

2010251955-IL-13 binding protein